Improving flu vaccines for older adults
A new mucosal adjuvant for augmenting influenza vaccines in elderly
This study is looking at a new ingredient that could make flu vaccines work better for older adults, helping to boost their immune response and provide stronger protection against the flu.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11078666 on NIH RePORTER |
What this research studies
This research investigates a new mucosal adjuvant designed to enhance the effectiveness of influenza vaccines specifically for elderly individuals. Current flu vaccines often fail to provide adequate protection due to the weakened immune response in older adults. The study will utilize a novel adjuvant that stimulates both humoral and cell-mediated immunity, potentially leading to better vaccine responses. Researchers will test this adjuvant in combination with flu vaccines in aged mice to evaluate its ability to induce strong immune responses and long-lasting protection.
Who could benefit from this research
Good fit: Ideal candidates for this research are elderly individuals, particularly those who may have weakened immune systems.
Not a fit: Patients who are not elderly or those with robust immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective flu vaccines for the elderly, significantly improving their protection against influenza.
How similar studies have performed: Previous research has shown promising results with similar adjuvant approaches, indicating potential for success in this area.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wu, Mei X — Massachusetts General Hospital
- Study coordinator: Wu, Mei X
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.